Abstract

PurposeWe quantitatively analyzed the characteristics of cone-beam computed tomography (CBCT) radiomics in different periods during radiotherapy (RT) and then built a novel nomogram model integrating clinical features and dosimetric parameters for predicting radiation pneumonitis (RP) in patients with esophageal squamous cell carcinoma (ESCC).MethodsAt our institute, a retrospective study was conducted on 96 ESCC patients for whom we had complete clinical feature and dosimetric parameter data. CBCT images of each patient in three different periods of RT were obtained, the images were segmented using both lungs as the region of interest (ROI), and 851 image features were extracted. The least absolute shrinkage selection operator (LASSO) was applied to identify candidate radiomics features, and logistic regression analyses were applied to construct the rad-score. The optimal period for the rad-score, clinical features, and dosimetric parameters were selected to construct the nomogram model and then the receiver operating characteristic (ROC) curve was used to evaluate the prediction capacity of the model. Calibration curves and decision curves were used to demonstrate the discriminatory and clinical benefit ratios, respectively.ResultsThe relative volume of total lung treated with ≥5 Gy (V5), mean lung dose (MLD), and tumor stage were independent predictors of RP and were finally incorporated into the nomogram. When the three time periods were modeled, the first period was better than the others. In the primary cohort, the area under the ROC curve (AUC) was 0.700 (95% confidence interval (CI) 0.568–0.832), and in the independent validation cohort, the AUC was 0.765 (95% CI 0.588–0.941). In the nomogram model that integrates clinical features and dosimetric parameters, the AUC in the primary cohort was 0.836 (95% CI 0.700–0.918), and the AUC in the validation cohort was 0.905 (95% CI 0.799–1.000). The nomogram model exhibits excellent performance. Calibration curves indicate a favorable consistency between the nomogram prediction and the actual outcomes. The decision curve exhibits satisfactory clinical utility.ConclusionThe radiomics model based on early lung CBCT is a potentially valuable tool for predicting RP. V5, MLD, and tumor stage have certain predictive effects for RP. The developed nomogram model has a better prediction ability than any of the other predictors and can be used as a quantitative model to predict RP.

Highlights

  • Among malignant tumors, the incidence rate of esophageal cancer (EC) is the seventh highest, and the mortality rate is sixth worldwide [1]

  • The 96 patients were divided into radiation pneumonitis (RP) (39 cases) and non-RP (57 cases) groups, and 9 clinical features and 7 dosimetric parameters that might be related to the occurrence of RP were included

  • Univariate analysis showed that tumor stage was correlated with ≥2 grade RP (c2 = 2.650, P = 0.008), and other factors, including age, sex, concurrent chemoradiotherapy or lack thereof, COPD status, smoking status, and RT dose, showed no significant differences between the two groups

Read more

Summary

Introduction

The incidence rate of esophageal cancer (EC) is the seventh highest, and the mortality rate is sixth worldwide [1]. If RP occurs, it seriously affects the patient’s quality of life and survival prognosis [4]. It is imperative for EC patients undergoing RT to identify this toxicity at the earliest possible time. The accurate prediction of RP is essential to facilitate individualized radiation dosing that leads to maximized therapeutic gain. In addition to dosimetric parameters, some clinical features (tumor stage, smoking history, preexisting lung diseases, concurrent chemotherapy, and radiation dose) are considered to be related to RP occurrence. In order to individually and precisely discern RP, an accurate predictive model incorporating multiple types of factors with superior clinical utility is urgently needed

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call